ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.33
1.50%
US Tech 100
19,167.20
2.31%
S&P 500
5,638.94
2.13%
US Dollar vs CAD
1.43875
0.00%
Bitcoin
83,961.58
0.00%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Jpmorgan Emerging Europe Middle East & Africa Securities Plc (JEMA) Share Price

Jpmorgan Emerging Europe Middle East & Africa Securities Plc

Jpmorgan Emerging Europe Middle East & Africa Securities Plc (JEMA)

JPMorgan ActiveBuilders Emerging Markets Equity ETF
290.00
18.00
(6.62%)
Closed March 15 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
290.00
Bid
280.00
Ask
290.00
Volume
393,417
272.00 Day's Range 297.00
72.00 52 Week Range 297.00
Market Cap
117.265M
Previous Close
272.00
Open
282.00
Last Trade
172
@
290
(O)
Last Trade Time
Financial Volume
1,124,591p
VWAP
285.8522
Average Volume (3m)
108,352
Shares Outstanding
40,436,176
Dividend Yield
0.17%
PE Ratio
46.33
Earnings Per Share (EPS)
0.06
Revenue
3.44M
Net Profit
2.53M

About Jpmorgan Emerging Europe Middle East & Africa Securities Plc

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Website
www.jpmeemeaseurities.com
Headquarters
London, Gbr
Founded
-
Jpmorgan Emerging Europe Middle East & Africa Securities Plc is listed in the Mgmt Invt Offices, Open-end sector of the London Stock Exchange with ticker JEMA. The last closing price for Jpmorgan Emerging Europe... was 272p. Over the last year, Jpmorgan Emerging Europe... shares have traded in a share price range of 72.00p to 297.00p.

Jpmorgan Emerging Europe... currently has 40,436,176 shares outstanding. The market capitalization of Jpmorgan Emerging Europe... is £109.99 million. Jpmorgan Emerging Europe... has a price to earnings ratio (PE ratio) of 46.33.

Ask ADVFN Intelligence (AI)

JEMA Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13614.1732283465254297254128512272.76686929DE
43815.0793650794252297232177062262.14246975DE
129548.7179487179195297176108352238.97826191DE
2619019010029710092569207.97559235DE
521651321252977281376167.11506922DE
156206.9248.97713598183.12977283671136.27447412DE
260206.9248.97713598183.12977283671136.27447412DE

JEMA - Frequently Asked Questions (FAQ)

What is the current Jpmorgan Emerging Europe... share price?
The current share price of Jpmorgan Emerging Europe... is 290.00p
How many Jpmorgan Emerging Europe... shares are in issue?
Jpmorgan Emerging Europe... has 40,436,176 shares in issue
What is the market cap of Jpmorgan Emerging Europe...?
The market capitalisation of Jpmorgan Emerging Europe... is GBP 109.99M
What is the 1 year trading range for Jpmorgan Emerging Europe... share price?
Jpmorgan Emerging Europe... has traded in the range of 72.00p to 297.00p during the past year
What is the PE ratio of Jpmorgan Emerging Europe...?
The price to earnings ratio of Jpmorgan Emerging Europe... is 46.33
What is the cash to sales ratio of Jpmorgan Emerging Europe...?
The cash to sales ratio of Jpmorgan Emerging Europe... is 34.08
What is the reporting currency for Jpmorgan Emerging Europe...?
Jpmorgan Emerging Europe... reports financial results in GBP
What is the latest annual turnover for Jpmorgan Emerging Europe...?
The latest annual turnover of Jpmorgan Emerging Europe... is GBP 3.44M
What is the latest annual profit for Jpmorgan Emerging Europe...?
The latest annual profit of Jpmorgan Emerging Europe... is GBP 2.53M
What is the registered address of Jpmorgan Emerging Europe...?
The registered address for Jpmorgan Emerging Europe... is 60 VICTORIA EMBANKMENT, LONDON, EC4Y 0JP
What is the Jpmorgan Emerging Europe... website address?
The website address for Jpmorgan Emerging Europe... is www.jpmeemeaseurities.com
Which industry sector does Jpmorgan Emerging Europe... operate in?
Jpmorgan Emerging Europe... operates in the MGMT INVT OFFICES, OPEN-END sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GCMGcm Resources Plc
2.80p
(47.37%)
7.51M
SNGSynairgen Plc
1.26p
(40.00%)
2.09M
THRUThruvision Group Plc
0.90p
(38.46%)
10.74M
NARFNarf Industries Plc
0.45p
(38.46%)
18.45M
XTRXtract Resources Plc
0.90p
(28.57%)
12.34M
ENETEthernity Networks Ltd
0.0425p
(-32.00%)
250.35M
BIOMBiome Technologies Plc
1.00p
(-20.00%)
863.66k
PYXPyx Resources Limited
1.60p
(-17.74%)
415.36k
ADMEAdm Energy Plc
0.25p
(-16.67%)
1.04M
SYMESupply@me Capital Plc
0.003p
(-14.29%)
188.86M
PREMPremier African Minerals Limited
0.01175p
(12.98%)
1.45B
CPAICapai Plc
0.135p
(14.89%)
1B
UKOGUk Oil & Gas Plc
0.011p
(4.76%)
350.88M
ENETEthernity Networks Ltd
0.0425p
(-32.00%)
250.35M
EMEEmpyrean Energy Plc
0.11p
(-10.20%)
191.13M

Discussion

View Full Feed
Polymer Paul Polymer Paul 2 minutes ago
Jeunke ... Your a fraud. You have multiple accounts on here too .. you weird old man. You need to disappear. .. instead you are here still.. trying to con new investors out of there money. Rat bag scum you are !
LWLG
Lykiri Lykiri 3 minutes ago
Thanks hyperopia.
It is speculative as to why additional space has been leased, as there has been no official announcement from Northwest Biotherapeutics, but the space at Unity Campus seems primarily intended for R&D and product development, not leukapheresis, IMO. Given the recent collabora
NWBO
Investor2014 Investor2014 5 minutes ago
Yes and of course given your posting history here I fully expect you must be making groundbreaking contribution to the world too.
AVXL
edbi46 edbi46 6 minutes ago
RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an electromagnetic field at the point
BMI LMT QUBT
Pink Lady Pink Lady 7 minutes ago
You silly little boy...
that you come now and say these things. And when you call out on someone please have the courage to tag him instead of talking behind his back
@stervc
MONI
hardlesson hardlesson 11 minutes ago
Hey, where have you been? I'm assuming you're still hanging on to a large stack of shares here?

Turned out to be a huge disappointment for me so far, but hope things turn around for those that deserve a reward for holding so long.

Management has disrespected sharehol
SHMN
Researchfyi Researchfyi 20 minutes ago
n case anyone missed it the ring company closed at a new all time low of 0.1766 cents on Friday and had a record low on Thursday of 0.172 cents.

Which poster here touted and shouted that the ring company was a screaming buy and that you had to be a fool more or less for not buying, wh
LQMT
getmenews getmenews 34 minutes ago
Dear World Liberty, It's time to advise what the strategic reserve implies when you mean it will be a reserve, it will be your reserve right?
BTCUSD
joyceschoice joyceschoice 1 hour ago
https://www.youtube.com/watch?v=4ymPHzIkvug
CaptBeer CaptBeer 1 hour ago
That's the other shoe that will drop just like they did in the previous MARINE Patents trial. Only this time we hope our counsel will be ready for schenanegans like cropped tables. 
AMRN
wshaw14 wshaw14 1 hour ago
While the following is true "You will have to recapture all the depreciation and capital gains" except 0% Rate: Single filers with taxable income up to $48,350; Married filing jointly up to $96,700; Married filing separately up to $48,3503. This means for example if one is married and over 65 person
ET
getmenews getmenews 1 hour ago
I don't suspect we see 2.50 again till after the BR filing, all the other ETF filings are non events!

Nice day
XRPUSD
getmenews getmenews 1 hour ago
So where to next? Lower support line in my charts, which, I know you see!

Nice day
XRPUSD
JusticeWillWin JusticeWillWin 1 hour ago
Be safe!

Up to like 7 or 8 fires now NOPEY well over 10 now
COOP
Mr79 Mr79 1 hour ago
https://media3.giphy.com/media/f6W3eijFZUIwiNY0xp/giphy.gif?cid=6c09b952klfx6y7jxsop94baxo5k1w85a23kjntrjlfprodb&ep=v1_internal_gif_by_id&rid=giphy.gif&ct=g
CNNA
Slojab Slojab 1 hour ago
Yeah, perhaps the guy is fabricating the story. But like you said, you wouldn't be at all surprised if it were true. And to even think it is, is pretty telling.
CosmicWatcher161 CosmicWatcher161 1 hour ago
Seems like a new 2024 annual report is added

https://s204.q4cdn.com/707617056/files/doc_financials/2024/ar/8e6783e2-86ea-429d-90cc-46b2afae5e0d.pdf
SMCI
WooptdooU WooptdooU 1 hour ago
Yve's answer to whether the product is ready? "We think so", is a defense. Like I say, it'll be interesting to watch an expert witness testify against expert witness, grifter, misguider, dr, dr lebby.
LWLG
Lykiri Lykiri 1 hour ago
Thanks for sharing pgsd.
https://x.com/Siobhain_Mc/status/1900610727351615512

https://commonslibrary.parliament.uk/research-briefings/cbp-10198/
NWBO
Lykiri Lykiri 2 hours ago
You're not the only one wondering why the MHRA is taking so long. Even MP Siobhain McDonagh called their performance on glioblastoma 'woeful' and questioned whether they should be abolished altogether.

March 13
https://x.com/Siobhain_Mc/status/1900226965656813953
NWBO
Investor2014 Investor2014 2 hours ago
On top of Missling having no fallback revenue opportunities without EMA approval from current trials, a share buyback would be just about the best way to erode the company's cash balance and ability to fund new trials.
AVXL
maverick_1 maverick_1 2 hours ago
PROFOUND Implications of CO Mingling two heretofore separate & distinct therapies
CELL & GENE ( latter is approaching a decade in development & approved in many blood cancers)

Perhaps why $NWBO MAESTRO spent 2 years in negotiations for mid 2024 Cross Licensing with Roswell Pa
NWBO
nowwhat2 nowwhat2 2 hours ago
wth
BKMT
joyceschoice joyceschoice 2 hours ago
https://www.youtube.com/watch?v=xZlxOvHwcq0
nowwhat2 nowwhat2 2 hours ago
wow.....that was 9 years ago.....Now what ?
https://www.mining.com/pdac-jv-video-dundee-sustainables-clevr-chemistry-cuts-gold-extraction-time-to-an-hour/
Holy
https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=ca%3Adst&x=0&y=0&time=100&startd
DST

Your Recent History

LSE
JEMA
Jpmorgan Emerging Europe...
LSE
41WB
Lloyds Bk.44
USOTC
AAMTF
Armada Mercantile (PK)
COIN
YBANUSD
BananoDOS
NASDAQ
SMIH
Summit Healthcare Acquis...
USOTC
ESIFF
AI Artificial Intelligen... (QB)
LSE
JSGA
Jpmorgan Japan Small Cap...
NASDAQ
PRTK
Paratek Pharmaceuticals
LSE
BCOM
L&g All Comm
USOTC
SNTMF
SenseTime (PK)
LSE
BS26
Res.mort.1'a'br
LSE
0LLR
Vaneck Vectors Brazil Sm...
NASDAQ
VCNX
Vaccinex
LSE
XEUM
Xeu Midcap
UPBT
GMTKRW
GMT [STEPN]
NASDAQ
SCMAU
Seaport Calibre Material...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads